For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a curative treatment ...
Newswise — PHOENIX — A Mayo Clinic-led international phase 3 study found that a new immunotherapy helped many patients with an aggressive form of bladder cancer keep their bladder instead of having it ...
At 2 years, metastasis-free survival was 81% and overall survival was 83%. HealthDay News — Pembrolizumab combined with gemcitabine-based chemoradiation is feasible and effective in patients with ...
Most people with bladder cancer begin treatment by having surgery to remove their cancer. If bladder cancer has spread beyond your bladder, you might have chemotherapy first. This can help treat ...
Bladder cancer remains one of the most common and deadly malignancies worldwide, and researchers continue to hunt for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results